Nine Square Therapeutics
New York, US · Founded 2020 · Delaware corporation
Find your way into Nine Square Therapeutics
Sign up to see every warm intro you have to Nine Square Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nine Square Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 1 round · 2020
▶$4.2MraisedFeb 2021 · 1 investors · BiotechnologyRule 506(b)
▶$4.2MraisedFeb 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew JacobsonDirector
- Seth HarrisonDirector
- Spiros LirasExecutive Officer, Director
- Michael EhlersDirector
- Offering amount
- $50M
- Amount sold
- $4.2M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nine Square Therapeutics raised?
- Nine Square Therapeutics has disclosed $4.2M raised across 1 round.
- Where is Nine Square Therapeutics headquartered?
- Nine Square Therapeutics is headquartered in New York, US.

